Spectrum Pharmaceuticals/ US84763A1088 /
| 2023-07-31 9:59:52 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.03USD | - | 122,550 Turnover: 124,444.33 |
-Bid Size: - | -Ask Size: - | 211.42 mill.USD | - | - |
Assets
| 2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 2.5000 | 1.5000 | 1.4050 | .9180 | .4490 | ||||||
| Intangible Assets | 202.3000 | 231.4000 | 230.1000 | 190.3350 | 164.2340 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | - | 267.5640 | 229.8960 | 212.1180 | ||||||
| Inventories | 14.5000 | 13.5000 | 9.2000 | 4.1760 | 8.7150 | ||||||
| Accounts Receivable | 92.2000 | 49.5000 | 70.7580 | 30.3840 | 39.7820 | ||||||
| Cash and Cash Equivalents | 139.7000 | 156.3000 | 129.9420 | 139.7410 | 158.2220 | ||||||
| Current Assets | 264.9000 | 235.2000 | 222.4690 | 191.3240 | 216.6500 | ||||||
| Total Assets | 506.3000 | 499.2000 | 490.0330 | 421.2200 | 428.7680 | ||||||
Liabilities
| 2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 95.3000 | 79.8000 | 8.9940 | 26.6840 | 30.4880 | ||||||
| Long-term debt | 75 | - | 96.2980 | 101.5480 | 97.0430 | ||||||
| Liabilities to Banks | 75 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Provisions | 2.9000 | 7.2000 | 6.6000 | 6.8000 | 6.7000 | ||||||
| Liabilities | 221.4000 | 217.5000 | 235.4790 | 208.3630 | 192.7420 | ||||||
| Share Capital | .0600 | .0640 | .0660 | .0680 | .0800 | ||||||
| Total Equity | 284.8000 | 281.6000 | 254.5540 | 212.8570 | 236.0260 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 506.3000 | 499.2000 | 490.0330 | 421.2200 | 428.7680 | ||||||
Income Statement
| 2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 267.7000 | 155.9000 | 186.8300 | 162.5560 | 146.4440 | ||||||
| Depreciation (total) | 6.7000 | 20.1000 | 25.3520 | 31.8690 | 26.4920 | ||||||
| Operating Result | 79.8000 | -38.8000 | -31.5690 | -40.7320 | -61.6280 | ||||||
| Interest Income | - | -2.2000 | -8.5840 | -9.0740 | -9.4350 | ||||||
| Income Before Taxes | 79 | -36.6000 | -43.5330 | -50.3790 | -70.8250 | ||||||
| Income Taxes | -15.6000 | 25.5000 | -2.1860 | -.4060 | 2.3130 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 95.5000 | -62.1000 | -45.7190 | -50.7850 | -68.5120 | ||||||
Per Share
Cash Flow
| 2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 72 | -2.1000 | -3.6270 | 6.7440 | -40.4590 | ||||||
| Cash Flow from Investing Activities | -114.7000 | -14.3000 | -21.8410 | 2.8380 | -.6790 | ||||||
| Cash Flow from Financing | 61 | 35.3000 | .8120 | 1.4710 | 59.6440 | ||||||
| Decrease / Increase in Cash | 18.5000 | 16.6000 | -26.3640 | 9.7990 | 18.4810 | ||||||
| Employees | 193 | 226 | 241 | 212 | 227 | ||||||
